At this time, posts about LegoChem Biosciences are rapidly increasing on portals and securities communities. Today, foreigners have tentatively sold a net 3,000 shares of LegoChem Biosciences, and institutions have sold a net 1,000 shares. LegoChem Biosciences is known as a synthetic new drug research and development company based on medicinal chemistry.

As of 11:30 AM on the 16th, the stock price of LegoChem Biosciences is 59,800 KRW, up 9.72% from the previous day, with a trading volume of 684,148 shares, which is 42.47% of the 5-day average trading volume. On June 10th, LegoChem Biosciences became a market issue with a sharp rise due to the news of a technology licensing contract for a COVID-19 treatment.

In addition to LegoChem Biosciences, posts by investors are also rapidly increasing for Hanil Danjo (024740), Dongbang Seonki (099410), and Hanwha Solutions Preferred (009835).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing